MSH|^~\&|LAB|CGH|||202002041316||ORU^R01|4161393|D|2.3|||AL|NE
PID|1|||CG2150|TEST^SANTA^||19641120|M||||||||||CG000137/18|
OBR|1|38829^LAB|00029307^0402:HC00001R^LAB^040220:HC1^38829|220.8900^INR^INR^^^6301-6||202002041039|202002041036|||||||202002041036||||||||||LAB|F||||
OBX|1|ST|220.9000^INR R^INR^^6301-6^6301-6|1|1.3^^Y||0.8-1.2|H||A^S|F|||202002041039
NTE|1||INR Therapeutic Ranges:
NTE|2||    Mechanical Heart Valves 2.5 - 3.5
NTE|3||    Other indications       2.0 - 3.0
OBR|2|38829^LAB|00029307^0402:HC00001R^LAB^040220:HC1^38829|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||202002041039|202002041036|||||||202002041036||||||||||LAB|F||||
OBX|1|ST|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9|1|45^^Y|s|23-32|H||A^S|F|||202002041039
NTE|1||Note: New reference range as of Sept 18, 2019
NTE|2||
NTE|3||New Therapeutic Range for FULL DOSE Unfractionated Heparin:
NTE|4||60 - 90 secs
NTE|5||For low dose and other indications, refer to appropriate
NTE|6||nomograms.
NTE|7||
NTE|8||Note: The previous full dose unfractionated heparin
NTE|9||therapeutic range was 75-99 secs
OBR|3|38829^LAB|00029307^0402:HC00001R^LAB^040220:HC1^38829|230.0610^PTTMIX^PTT Mixing Study^^^XBC1943-9||202002041039|202002041036|||||||202002041036||||||||||LAB|I||||
OBX|1|ST|230.1400^NORMALIMMED^NormalImmediate^^50754-1^50754-1|1|25^^Y|s||N||A^S|F|||202002041316
OBX|2|ST|230.1410^NORMALINCUB^Normal Incubated^^38276-2^38276-2|1|26^^Y|s||N||A^S|F|||202002041316
OBX|3|ST|230.1420^PATIENTIMMED^Patient Immediate^^14979-9^14979-9|1|44^^Y|s||N||A^S|F|||202002041316
OBX|4|ST|230.1430^PATIENTINCUB^Patient Incubated^^30322-2^30322-2|1|51^^Y|s||N||A^S|F|||202002041316
OBX|5|ST|230.1440^1:1MIXIMMED^1:1 MIX Immediate^^5946-9^5946-9|1|33^^Y|s||N||A^S|F|||202002041316
OBX|6|ST|230.1450^1:1MIXINCUB^1:1 MIX Incubated^^30323-0^30323-0|1|35^^Y|s||N||A^S|F|||202002041316
OBX|7|ST|230.1465^1:1INCSEPMIX^Incubated Separate + Mix^^49845-1^49845-1|1|32^^Y|s||N||A^S|F|||202002041316